Company News for March 4, 2010 – Corporate Summary
Zacks Market Commentaries (March 4th, 2010) Writes:
• Pfizer (NYSE:PFE) led DJIA stocks on the downside yesterday after Medivation (NASDAQ:MDVN) said its experimental treatment for Alzheimer's, Dimebon, developed with Pfizer, failed to show desired results in late-stage trials
• Anheuser-Busch InBev (NYSE:BUD) posted adjusted earnings of 55 cents a share, up from 44 cents, which missed Zacks projections by 5 cents, on combined revenues up 5% to $9.3 billion
• UBS (NYSE:UBS) upgraded Coca-Cola (NYSE:KO) to "buy" from "neutral," citing solid mid-single digit global volume growth
• Goldman Sachs (NYSE:GS) upgraded Royal Caribbean (NYSE:RCL) to "neutral" from "sell," and raised the price target to $27 from $23
• Piper Jaffray (NYSE:PJC) reiterated an "overweight" rating on Big Lots (NYSE:BIG), but raised the price target to $41 from $38
• Suntech Power (NYSE:STP) posted better-than-expected earnings of 27 cents a share, sharply up from Zacks estimates of 12 cents, on revenues of $583.6 million, well ahead of Zacks estimates of $471 million
• FBR reiterated its "outperform" rating on Anadarko (NYSE:APC)
...

![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)




